A C-type natriuretic peptide (CNP) analog approved for height growth in children with achondroplasia. FDA-approved 2021 (Voxzogo) and EMA-approved same year. Phase 3 trials showed…

Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic, 83-amino acid analog of human IGF-1, a critical hormone involved in growth and development. It…

An older non-selective growth hormone-releasing peptide (GHRP) with a real cortisol and prolactin elevation profile that worsens with chronic use.

An FDA-approved synthetic GHRH analog with a narrow but real indication: reducing excess visceral abdominal fat in HIV-infected patients on antiretroviral therapy.

GHRP-6 is a synthetic, first-generation hexapeptide growth hormone secretagogue (GHS). It was developed in the 1980s through systematic modification of the met-enkephalin structure to create…

GHRP-2 is a synthetic, potent, and selective hexapeptide growth hormone secretagogue (GHS). It was developed in the late 1980s and early 1990s as part of…

A modified GHRH (growth hormone-releasing hormone) analog with two distinct forms in circulation: with-DAC and without-DAC.

A selective growth hormone secretagogue (GHRP) — pentapeptide that stimulates GH release through the ghrelin receptor without the cortisol or prolactin elevation seen with older…

A synthetic GHRH(1-29) analog that was historically FDA-approved for pediatric growth hormone deficiency (Geref, 1997) but commercially discontinued by the manufacturer in 2006 — for…